16 Fanconi Anemia Clinical Trials in Sacramento, CA (2026)

Q: How do I join a clinical trial in Sacramento?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you.

Recruiting Fanconi Anemia Studies in Sacramento

NCT00196742Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status...

Sacramento, CA9,000 participantsGenzyme, a Sanofi Company

View Study Details

NCT06008197Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricul...

Sacramento, CAPHASE35,200 participantsColorado Prevention Center

View Study Details

NCT06033950Recruiting

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients with heart failure and reduced ejection fraction (HFrEF) who are intolerant or ineligible to receive tr...

Sacramento, CAPHASE32,600 participantsColorado Prevention Center

View Study Details

NCT06736574Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in p...

Sacramento, CAPHASE31,800 participantsCytokinetics

View Study Details

NCT06024746Recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)

Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized with heart failure....

Sacramento, CAPHASE31,500 participantsColorado Prevention Center

View Study Details

NCT05873634Recruiting

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of br...

Sacramento, CA1,000 participantsNorthwestern University

View Study Details

NCT06526195Recruiting

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced h...

Sacramento, CANA850 participantsAbbott Medical Devices

View Study Details

NCT07574593Recruiting

NORM-HF Pivotal Study

This is an international, multi-center, prospective, randomized, open-label blinded endpoint study designed to demonstrate that use of the FIRE1 NORM™ System in the management of New York Heart Associ...

Sacramento, CANA800 participantsFoundry Innovation & Research 1, Limited (FIRE1)

View Study Details

NCT05685303Recruiting

Alleviant ALLAY-HF Study

Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV...

Sacramento, CANA700 participantsAlleviant Medical, Inc.

View Study Details

NCT06898515Recruiting

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute dec...

Sacramento, CANA400 participantsReprieve Cardiovascular, Inc

View Study Details

NCT06812533Recruiting

Alleviant ALLAY-HFrEF Study

Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the A...

Sacramento, CANA350 participantsAlleviant Medical, Inc.

View Study Details

NCT06317662Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic leukemia (ALL) with a KMT2A gene rearrangem...

Sacramento, CAPHASE2153 participantsNational Cancer Institute (NCI)

View Study Details

NCT07508787Recruiting

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

The goal of this clinical trial is to learn if siplizumab can prevent rejection of a kidney transplant in adult participants with end stage kidney disease. The main questions it aims to answer are: H...

Sacramento, CAPHASE2120 participantsNefro Avillion Clinical Development, LLC

View Study Details

NCT04196842Recruiting

Heart Failure Precision Medicine Study

The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideli...

Sacramento, CANA100 participantsUniversity of California, Davis

View Study Details

NCT07494162Recruiting

Imaging Metabolic and Perfusion Changes in Acupuncture Therapy for Myofascial Pain Syndrome

This study will evaluate the clinical and biological effects of acupuncture for chronic low back pain associated with myofascial pain syndrome (MPS). In this randomized, participant- and assessor-bli...

Sacramento, CANA64 participantsUniversity of California, Davis

View Study Details

NCT05104502Recruiting

Immunomodulatory Effects of Fasting in Healthy Adults

This is a clinical trial assessing the effects of fasting on the immune system in healthy adults. Immune profiling, gene expression profiling, and flow cytometry on peripheral blood mononuclear cells ...

Sacramento, CANA4 participantsUniversity of California, Davis

View Study Details

About Fanconi Anemia Clinical Trials in Sacramento

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 16 fanconi anemia clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 24,641 participants. Research is being sponsored by Genzyme, a Sanofi Company, Colorado Prevention Center, Cytokinetics and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Sacramento — FAQ

Are there fanconi anemia clinical trials in Sacramento?

Yes, there are 16 fanconi anemia clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 16 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated October 18, 2026 from ClinicalTrials.gov